5081COVID-19 response capacity with the health systems – health information systems — based on information as at 15 January 2021Technical Documents · February 28, 2021
5082Capacité de riposte à la COVID-19 avec les systèmes de santé - systèmes d’information sanitaire — sur la base des informations disponibles au 15 janvier 2021Technical Documents · February 28, 2021
5083Mortalité et morbidité liées à la COVID-19 chez les prestataires de soins — sur la base des informations disponibles au 14 février 2021Technical Documents · February 28, 2021
5084Health workers in focus: policies and practices for successful public response to COVID-19 vaccination: strategic considerations for member states in the WHO European RegionTechnical Documents · February 26, 2021
5085Orientations sur la sécurité biologique en laboratoire en rapport avec la maladie à coronavirus 2019 (COVID-19) : orientations provisoires, 28 janvier 2021Technical Documents · February 25, 2021
5086Preparedness, prevention and control of COVID-19 in prisons and other places of detention: interim guidance, 8 February 2021Technical Documents · February 25, 2021
5088Памятка по применению вакцины против COVID-19: вакцина BNT162b2 Comirnaty® компаний Pfizer/BioNTech (международное непатентованное наименование: тозинамеран), Февраль 2021 r.Technical Documents · February 24, 2021
5089COVID-19 vaccine introduction and deployment costing tool (CVIC tool), 20 February 2021Technical Documents · February 23, 2021
5090Spécifications techniques des équipements de protection individuelle contre la maladie à coronavirus 2019 (COVID 19) : orientations provisoires, 13 novembre 2020Technical Documents · February 23, 2021
5092Using research evidence for policy-making: evidence briefs for policy. Virtual meeting for countries from Eastern Europe and Central Asia: report of the introductory session, 6 October 2020.Technical Documents · February 22, 2021
5093Maintaining a safe and adequate blood supply and collecting convalescent plasma in the context of the COVID-19 pandemic: interim guidance, 17 February 2021Technical Documents · February 22, 2021
5094Информационный бюллетень для работников здравоохранения: вакцина BNT162b2 Comirnaty® компаний Pfizer/BioNTech (международное непатентованное наименование: тозинамеран), Февраль 2021 r.Technical Documents · February 22, 2021
5095Health and well-being and the 2030 agenda for sustainable development in the WHO European region: an analysis of policy development and implementation. Report of the first survey to assess Member States’ activities in relation to the WHO European region roadmap to implement the 2030 agenda for sustainable developmentTechnical Documents · February 22, 2021
5096Anti-interleukin-6 therapies for hospitalized patients with COVID-19: a protocol for a prospective meta-analysis of randomized trials, 19 February 2021Technical Documents · February 19, 2021
5097Digital adaptation kit for antenatal care: operational requirements for implementing WHO recommendations in digital systems: web annex C: indicators tableTechnical Documents · February 18, 2021
5098Digital adaptation kit for antenatal care: operational requirements for implementing WHO recommendations in digital systems: web annex A: core data dictionaryTechnical Documents · February 18, 2021
5099Digital adaptation kit for antenatal care: operational requirements for implementing WHO recommendations in digital systems: web annex B: decision support logicTechnical Documents · February 18, 2021
5100Digital adaptation kit for antenatal care: operational requirements for implementing WHO recommendations in digital systems: web annex D: functional and non-functional requirementsTechnical Documents · February 18, 2021